Senti Biosciences Inc. (NASDAQ: SNTI) reported second quarter 2025 financial results and confirmed additional efficacy and durability data from its ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE